EP3278801
Lyfjasamsetning sem inniheldur mirabegrón
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.3.2016EP published:
13.11.2019EP application number:
16773147.0
EP translation filed:
12.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
30.3.2036Expiry date:
30.3.2027Next due date:
31.3.2027
Title:
PHARMACEUTICAL COMPOSITION CONTAINING MIRABEGRON
Timeline
Today
31.3.2016EP application
13.11.2019EP Publication
12.12.2019Translation submitted
15.1.2020Registration published
30.3.2027Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo, JP
Inventor
Name:
TAKAE, SeijiAddress:
Tokyo, JP
Name:
SAKAI, ToshiroAddress:
Tokyo, JP
Name:
KASASHIMA, YukiAddress:
Tokyo, JP
Name:
ANSEI, YurinaAddress:
Tokyo, JP
Name:
KIYOTA, TsuyoshiAddress:
Tokyo, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2015073911Date:
31.3.2015Country:
JP
Classification
Categories:
A61K 31/426, A61K 9/10, A61K 47/12, A61K 47/32, A61K 47/36, A61P 13/10, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 18.2.2020
Expires: 30.3.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 8.2.2021
Expires: 30.3.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.2.2022
Expires: 30.3.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.3.2023
Expires: 30.3.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 6.3.2024
Expires: 30.3.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.2.2025
Expires: 30.3.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 27.3.2026
Expires: 30.3.2027
Payer: Árnason Faktor ehf.